Emerging therapies in the management of Irritable Bowel Syndrome (IBS).
Saved in:
| Title: | Emerging therapies in the management of Irritable Bowel Syndrome (IBS). |
|---|---|
| Authors: | Elwing JE; St. Louis Veterans Affairs Medical Center, St. Louis, MO, USA.; Division of Gastroenterology, Washington University School of Medicine, St. Louis, MO, USA., Atassi H; Division of Gastroenterology, Hepatology, and Nutrition, University of Louisville School of Medicine, Louisville, KY, USA., Rogers BD; Division of Gastroenterology, Washington University School of Medicine, St. Louis, MO, USA.; Division of Gastroenterology, Hepatology, and Nutrition, University of Louisville School of Medicine, Louisville, KY, USA., Sayuk GS; St. Louis Veterans Affairs Medical Center, St. Louis, MO, USA.; Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA. |
| Source: | Expert opinion on emerging drugs [Expert Opin Emerg Drugs] 2022 Mar; Vol. 27 (1), pp. 55-73. Date of Electronic Publication: 2022 Mar 16. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 101135662 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7623 (Electronic) Linking ISSN: 14728214 NLM ISO Abbreviation: Expert Opin Emerg Drugs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
